Drugs Made In America Acquisition II Corp. DMII
$10.08
▲ +0.00% 24H
About
Drugs Made In America Acquisition II Corp. is a special purpose acquisition company (SPAC) established in 2024 with the primary objective of effecting business combinations through mergers, share exchanges, asset acquisitions, or similar transactions. The company targets the pharmaceutical industry, aiming to identify …
SectorFinancial Services
ExchangeNASDAQ
IndustryShell Companies
CountryUnited States
Employees0
TickerDMII
Statistics
Market Cap$642.1M
Revenue (TTM)—
Net Income$4.2M
Net Margin—
EPS—
P/E72.00
P/S—
P/B1.30
EV/EBITDA-346.34
ROE0.9%
Dividend Yield—
Price$10.08
Data: Twelve Data · Revenue = mcap / P/S